Newly identified prostate cell type may help explain why enlarged prostate develops in one region of gland

Researchers at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center have identified a distinct type of prostate cell ...
BIOENGINEER

Exploding immune cells may explain why prostate drug therapy fails in some men

A new study shows that 5-alpha-reductase inhibitor therapy can trigger macrophage pyroptosis, HMGB1–AGER-driven epithelial ...
Public Broadcasting Service (PBS)

Men's Health

Good evening and welcome to Doctors on Call back on our we're back on our 45th season at this time. I'm Dr. Ray Christensen, ...
BioWorld

RNA panel detects and differentiates prostate cancer from benign prostate hyperplasia

Prostate cancer is still one of the main causes of cancer death among men; while prostate-specific antigen (PSA) testing is done for screening, there are recommendations against its use due to its ...

Robotic prostate cancer surgery has a 3.3% transfusion rate; readmission and reoperation rates also low

"Robotic Prostate Cancer Surgery Has a 3.3% Transfusion Rate; Readmission and Reoperation Rates Also Low" ...
Health Chosun

Incheon Naeun Hospital Recruits Urologist Kim Hyun Woo to Strengthen Prostate Cancer Robotic Surgery Program

Incheon Naeun Hospital has recruited urology specialist Kim Hyun Woo as director of its Prostate Center, and he began seeing ...
BIOENGINEER

New Biomarkers and AI Aim to Cut Unnecessary Prostate Biopsies Before the Needle

A new review in Medical Oncology details how liquid biomarkers, advanced imaging, and artificial intelligence are transforming pre-biopsy discrimination of prostate cancer from benign disease.